Literature DB >> 34183371

Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency.

Tom Le Voyer1,2, Sonoko Sakata3, Miyuki Tsumura3, Taushif Khan4, Ana Esteve-Sole5, Bandar K Al-Saud6, Hatice Eke Gungor7, Prasad Taur8, Valentine Jeanne-Julien9,2, Mette Christiansen10, Lisa-Maria Köhler11, Gehad Eltayeb ElGhazali12, Jérémie Rosain9,2, Shiho Nishimura3, Fumiaki Sakura3, Matthieu Bouaziz9,2, Carmen Oleaga-Quintas9,2, Alejandro Nieto-Patlán9,2,13, Àngela Deyà-Martinez5, Yasemin Altuner Torun14, Anna-Lena Neehus9,2, Manon Roynard9,2, Sefika Elmas Bozdemir15, Nawal Al Kaabi12, Moza Al Hassani12, Irina Mersiyanova16, Flore Rozenberg17, Carsten Speckmann18,19, Ina Hainmann20, Fabian Hauck11, Mohammed Hamdan Alzahrani21, Sami Hussain Alhajjar6, Saleh Al-Muhsen6,22, Theresa Cole23, Ramsay Fuleihan24, Peter D Arkwright25, Raffaele Badolato26, Laia Alsina5, Laurent Abel9,2,27, Mukesh Desai8, Hamoud Al-Mousa6, Anna Shcherbina28, Nico Marr4, Stéphanie Boisson-Dupuis9,2,27, Jean-Laurent Casanova9,2,27,29, Satoshi Okada3, Jacinta Bustamante1,2,27,30.   

Abstract

Autosomal recessive (AR) STAT1 deficiency is a severe inborn error of immunity disrupting cellular responses to type I, II, and III IFNs, and IL-27, and conferring a predisposition to both viral and mycobacterial infections. We report the genetic, immunological, and clinical features of an international cohort of 32 patients from 20 kindreds: 24 patients with complete deficiency, and 8 patients with partial deficiency. Twenty-four patients suffered from mycobacterial disease (bacillus Calmette-Guérin = 13, environmental mycobacteria = 10, or both in 1 patient). Fifty-four severe viral episodes occurred in sixteen patients, mainly caused by Herpesviridae viruses. Attenuated live measles, mumps, and rubella and/or varicella zoster virus vaccines triggered severe reactions in the five patients with complete deficiency who were vaccinated. Seven patients developed features of hemophagocytic syndrome. Twenty-one patients died, and death was almost twice as likely in patients with complete STAT1 deficiency than in those with partial STAT1 deficiency. All but one of the eight survivors with AR complete deficiency underwent hematopoietic stem cell transplantation. Overall survival after hematopoietic stem cell transplantation was 64%. A diagnosis of AR STAT1 deficiency should be considered in children with mycobacterial and/or viral infectious diseases. It is important to distinguish between complete and partial forms of AR STAT1 deficiency, as their clinical outcome and management differ significantly.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34183371      PMCID: PMC8702442          DOI: 10.4049/jimmunol.2001451

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  73 in total

1.  Estimating the age of rare disease mutations: the example of Triple-A syndrome.

Authors:  E Genin; A Tullio-Pelet; F Begeot; S Lyonnet; L Abel
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

2.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

3.  A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis.

Authors:  Mohammed F Alosaimi; Michelle C Maciag; Craig D Platt; Raif S Geha; Janet Chou; Lisa M Bartnikas
Journal:  J Allergy Clin Immunol       Date:  2019-05-15       Impact factor: 10.793

Review 4.  IL-10 and IL-10 receptor defects in humans.

Authors:  Erik-Oliver Glocker; Daniel Kotlarz; Christoph Klein; Neil Shah; Bodo Grimbacher
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 5.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

6.  Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Jessica Leung; Subhadra Siegel; James F Jones; Cynthia Schulte; Debra Blog; D Scott Schmid; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

Review 7.  Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes.

Authors:  Stephanie Boisson-Dupuis; Xiao-Fei Kong; Satoshi Okada; Sophie Cypowyj; Anne Puel; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2012-05-30       Impact factor: 7.486

8.  Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

Authors:  Nicholas Hernandez; Giorgia Bucciol; Leen Moens; Jérémie Le Pen; Mohammad Shahrooei; Ekaterini Goudouris; Afshin Shirkani; Majid Changi-Ashtiani; Hassan Rokni-Zadeh; Stephen J Seligman; Laurent Abel; Paul Hertzog; Nico Marr; Reinaldo de Menezes Martins; Isabelle Meyts; Qian Zhang; Margaret R MacDonald; Charles M Rice; Jean-Laurent Casanova; Emmanuelle Jouanguy; Xavier Bossuyt; Esra Hazar Sayar; Ismail Reisli; Alain Lefevre-Utile; Dick Zijlmans; Andrea Jurado; Ruben Pholien; Scott Drutman; Serkan Belkaya; Aurelie Cobat; Robbert Boudewijns; Dirk Jochmans; Johan Neyts; Yoann Seeleuthner; Lazaro Lorenzo-Diaz; Chibuzo Enemchukwu; Ian Tietjen; Hans-Heinrich Hoffmann; Mana Momenilandi; Laura Pöyhönen; Marilda M Siqueira; Sheila M Barbosa de Lima; Denise C de Souza Matos; Akira Homma; Maria de Lourdes S Maia; Tamiris Azamor da Costa Barros; Patricia Mouta Nunes de Oliveira; Emersom Ciclini Mesquita; Rik Gijsbers; Shen-Ying Zhang
Journal:  J Exp Med       Date:  2019-07-03       Impact factor: 14.307

9.  Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data.

Authors:  Meredith Woodward; Ann Marko; Susan Galea; Barry Eagel; Walter Straus
Journal:  Open Forum Infect Dis       Date:  2019-08-01       Impact factor: 3.835

10.  A Novel Complete Autosomal-Recessive STAT1 LOF Variant Causes Immunodeficiency with Hemophagocytic Lymphohistiocytosis-Like Hyperinflammation.

Authors:  Daniel F R Boehmer; Lisa M Koehler; Thomas Magg; Philipp Metzger; Meino Rohlfs; Julia Ahlfeld; Anita Rack-Hoch; Karl Reiter; Michael H Albert; Stefan Endres; Simon Rothenfusser; Christoph Klein; Lars M Koenig; Fabian Hauck
Journal:  J Allergy Clin Immunol Pract       Date:  2020-06-27
View more
  7 in total

1.  Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells.

Authors:  Rui Yang; Danielle T Avery; Katherine J L Jackson; Masato Ogishi; Ibtihal Benhsaien; Likun Du; Xiaofei Ye; Jing Han; Jérémie Rosain; Jessica N Peel; Marie-Alexandra Alyanakian; Bénédicte Neven; Sarah Winter; Anne Puel; Bertrand Boisson; Kathryn J Payne; Melanie Wong; Amanda J Russell; Yoko Mizoguchi; Satoshi Okada; Gulbu Uzel; Christopher C Goodnow; Sylvain Latour; Jalila El Bakkouri; Aziz Bousfiha; Kahn Preece; Paul E Gray; Baerbel Keller; Klaus Warnatz; Stéphanie Boisson-Dupuis; Laurent Abel; Qiang Pan-Hammarström; Jacinta Bustamante; Cindy S Ma; Jean-Laurent Casanova; Stuart G Tangye
Journal:  Sci Immunol       Date:  2022-07-22

2.  Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.

Authors:  Xuemei Chen; Junjie Chen; Ran Chen; Huilin Mou; Gan Sun; Lu Yang; Yanjun Jia; Qin Zhao; Wen Wen; Lina Zhou; Yuan Ding; Xuemei Tang; Jun Yang; Yunfei An; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2022-08-17       Impact factor: 8.542

3.  Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency.

Authors:  Tessa Mollie Campbell; Zhiyong Liu; Qian Zhang; Jean-Laurent Casanova; Isabelle Meyts; Yenan T Bryceson; Marcela Moncada-Velez; Laura E Covill; Peng Zhang; Ilad Alavi Darazam; Paul Bastard; Lucy Bizien; Giorgia Bucciol; Sara Lind Enoksson; Emmanuelle Jouanguy; Şemsi Nur Karabela; Taushif Khan; Yasemin Kendir-Demirkol; Andres Augusto Arias; Davood Mansouri; Per Marits; Nico Marr; Isabelle Migeotte; Leen Moens; Tayfun Ozcelik; Isabelle Pellier; Anton Sendel; Mohammad Shahrooei; C I Edvard Smith; Isabelle Vandernoot; Karen Willekens; Peter Bergman; Laurent Abel; Aurélie Cobat
Journal:  J Exp Med       Date:  2022-06-07       Impact factor: 17.579

Review 4.  Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations.

Authors:  Magda Carneiro-Sampaio; Adriana Almeida de Jesus; Silvia Yumi Bando; Carlos Alberto Moreira-Filho
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.569

5.  Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

Authors:  Qian Zhang; Daniela Matuozzo; Jérémie Le Pen; Qiang Pan-Hammarström; Bertrand Boisson; Paul Bastard; Helen C Su; Stéphanie Boisson-Dupuis; Laurent Abel; Charles M Rice; Shen-Ying Zhang; Aurélie Cobat; Jean-Laurent Casanova; Danyel Lee; Leen Moens; Takaki Asano; Jonathan Bohlen; Zhiyong Liu; Marcela Moncada-Velez; Yasemin Kendir-Demirkol; Huie Jing; Lucy Bizien; Astrid Marchal; Hassan Abolhassani; Selket Delafontaine; Giorgia Bucciol; Gulsum Ical Bayhan; Sevgi Keles; Ayca Kiykim; Selda Hancerli; Filomeen Haerynck; Benoit Florkin; Nevin Hatipoglu; Tayfun Ozcelik; Guillaume Morelle; Mayana Zatz; Lisa F P Ng; David Chien Lye; Barnaby Edward Young; Yee-Sin Leo; Clifton L Dalgard; Richard P Lifton; Laurent Renia; Isabelle Meyts; Emmanuelle Jouanguy; Lennart Hammarström
Journal:  J Exp Med       Date:  2022-06-16       Impact factor: 17.579

Review 6.  From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Cell       Date:  2022-08-18       Impact factor: 66.850

7.  Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

Authors:  Qian Zhang; Andrés Pizzorno; Lisa Miorin; Paul Bastard; Adrian Gervais; Tom Le Voyer; Lucy Bizien; Kai Kisand; Anne Puel; Emmanuelle Jouanguy; Laurent Abel; Aurélie Cobat; Sophie Trouillet-Assant; Adolfo García-Sastre; Jean-Laurent Casanova; Jeremy Manry; Jérémie Rosain; Quentin Philippot; Kelian Goavec; Blandine Padey; Anastasija Cupic; Emilie Laurent; Kahina Saker; Martti Vanker; Karita Särekannu; Tamara García-Salum; Marcela Ferres; Nicole Le Corre; Javier Sánchez-Céspedes; María Balsera-Manzanero; Jordi Carratala; Pilar Retamar-Gentil; Gabriela Abelenda-Alonso; Adoración Valiente; Pierre Tiberghien; Marie Zins; Stéphanie Debette; Isabelle Meyts; Filomeen Haerynck; Riccardo Castagnoli; Luigi D Notarangelo; Luis I Gonzalez-Granado; Nerea Dominguez-Pinilla; Evangelos Andreakos; Vasiliki Triantafyllia; Carlos Rodríguez-Gallego; Jordi Solé-Violán; José Juan Ruiz-Hernandez; Felipe Rodríguez de Castro; José Ferreres; Marisa Briones; Joost Wauters; Lore Vanderbeke; Simon Feys; Chen-Yen Kuo; Wei-Te Lei; Cheng-Lung Ku; Galit Tal; Amos Etzioni; Suhair Hanna; Thomas Fournet; Jean-Sebastien Casalegno; Gregory Queromes; Laurent Argaud; Etienne Javouhey; Manuel Rosa-Calatrava; Elisa Cordero; Teresa Aydillo; Rafael A Medina
Journal:  J Exp Med       Date:  2022-09-16       Impact factor: 17.579

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.